A class action lawsuit has been commenced against Nymox Corp. and its board of directors on behalf of shareholders that purchased their shares between January 2011 and November 2014.
The allegation is that Nymox failed to disclose material information affecting the Phase 3 clinical trials for its proprietary drug NX-1207 for the treatment of benign prostatic hyperplastic (BPH).
Scorpio Gold {TSX.V SGN} Intersects 1.12 g/t Gold over 36.58 meters on the NW Brodie Trend, Mineral Ridge Project, Nevada, USA.
The Brodie Trend is outside the area of the current resource, and CEO Peter Hawley commented “we have an opportunity to potentially outline a significant resource in an area that until this year was held under a privately held patented mineral claim. The claim”
Terrace Energy {TSX.V: TZR} report that three well test results will be available in early December.
The company has expectations that these three wells will perform in a consistent manner to the earlier seven wells drilled at the site, and produce around 1,000 BOEPD
Scorpio Gold {TSX.V: SGN} have announced the passing of the 100,000 ounces of gold production at Mineral Ridge, a significant achievement.
This was achieved with Q3 production of 11,228 ounces, lighter than in previous quarters as low grade ore was worked through, but Scorpio President Steve Roebuck confirmed that guidance of 40 – 45,000 production ounces for the full year remains on target.
Continue reading
Range Energy arranges $1-million private placement
Range Energy {CSE: RGO} CEO Toufic Chahine reports that Range Energy have arranged a non brokered financing of $1 million in order to maintain their obligations on the Khalakan block in Iraqi Kurdistan.
Previous financings have been supported by Gulf LNG, a private US based investment fund who also hold a substantial position in Canadian listed Western Zagros.{WZR.V}
Range Energy is listed on the Canadian Securities Exchange.
Continue reading
Cartier Resources {TSX.V: ECR} have announced a binding letter of agreement with Donner Metals {TSX.V: DON} on an option to purchase an interest in respect of ECR’s Dollier Gold Project.
On paper this looks a very good deal for ECR, as it brings $400K into the treasury this year, plus 150K Don shares, and they have a free carry on 3,000 metres of drilling due to be carried out in November at the property.
A nice bit of business negotiated by Philippe Cloutier.
Terrace Energy {TSX.V: TZR} announces the successful completion of the Price 1H well, with strong hydrocarbon flows, and confirms that production operations have already begun.
Production results will be announced once flow rates have stabilised, as per the industry norm.
Terrace also updated with developments on all their other principal projects
Cartier Resources find gold potential in new zones at Chimo.
Philippe Cloutier, CEO and President of Cartier Resources {TSX.V: ECR} informed the market that following an interpretation of the zones 6 and 6B, in the south area of the Chimo property, two new gold bearing zones plus several areas of mineralization had been discovered.
A key factor is the similarity between the known Central Area and the new South Area zones.
Inovio Pharma {NASDAQ: EVO} has confirmed that they will initiate human trials of their Ebola virus vaccine in H1 2015, in conjunction with Korean based partner GeneOne Life Science.
Animal testing of the vaccine has proven successful, and the race is on for an effective vaccine after dire predictions of possible infection rates in Africa have been made by the US health officials.
Colonial Announces Receipt of Work Permit for Its Flatbed Property
Colonial Coal pleased the market by announcing the receipt of a Phase 1 Work Permit for its Flatbed property
located in the prolific Peace River Coal region of British Colombia, Canada.
The Flatbed property abuts properties owned by Teck and Peace River Coal.
Flatbed is considered to have good potential for a new high quality coking coal discovery, and the first drill
results will be eagerly awaited.
Continue reading
Inovio pharma {NASDAQ: INO} Expands HPV Immunotherapy Development to Aerodigestive Cancers.
Inovio Pharma have initiated a Phase 1 clinical trial for their INO-3016, targeting HPV-6, the cause of most human Aerodigestive cancers, which effect the lips, mouth, tongue, throat, vocal cords, and other oral areas.
The motivator to achieve this is the unmet needs of patients suffering from this form of cancer, and the opportunity to take first mover advantage in this critical area.
Continue reading
Cartier Resources {TSX.V: ECR} President and CEO Philippe Cloutier has followed on from his previous news release by announcing the result of the compilation and interpretation of historical data, at ECR’s Chimo mine.
“The quality and quantity of gold intersections comprising the extensions of the mined and unmined zones as well as the new discoveries define the upside for the project” the upbeat CEO added.
Management of Scorpio Gold Corp. {TSX.V: SGN} reported new drilling results in a new area of exploration, the Brodie Satellite Deposit at their Missouri Claim, at Mineral Ridge (70%) that show the potential to possibly expand the LOM.
These promising drill results, located outside the existing defined resource area and pit outlines is a continuation of their run of good news releases during the last few months.
Management believe that these results suggest the potential to build a resource in the Missouri claim area
In a surprise move, Inovio Pharmaceuticals has announced their intention to switch markets, leaving the NYSE, and moving over to the NASDAQ Global Select Market, with effect from September 15th 2014.
The feeling is that this will bring more attention to Inovio, as this is the market where most peers reside, and will therefore bring Inovio more into focus with those that invest in the sector.
Continue reading
Colonial Coal {TSX.V: CAD}
Canadian coal mining industry veteran David Austin, President and CEO of Colonial Coal runs through the company’s projects and explains the fundamental difference between coking and metallurgical coal.
Cartier Resources {TSX.V: ECR}
Cartier Resources President and CEO Philippe Cloutier announced the discovery of three mineralised zones with high exploration at their Chimo Mine project, located in Val-d’Or, Quebec, Canada.
“The North Area of the property shows many exploration targets” comments Philippe Cloutier, President and CEO, adding “the high grades and widths of the mineralization define targets that start from surface and extend at depth”.
Continue reading
Scorpio Gold {TSX.V: SGN} announce lower production and revenue figures YOY.
Installation of the new carbon column will increase the processing of pregnant leach solution and as a result, lower leach pad inventory and increase production.
WesternZagros {TSX.V: WZR} announce they declined a $1.46 per share offer for the company!
WZR are raising $400 million to fund their work programs on the Garmian and Kurdamir blocks.
Continue reading
Scorpio Gold {TSX.V:SGN} continued their run of news releases to the market with a further drilling update from the Bluelite Deposit at Mineral Ridge, Nevada.
Of particular note are the shallow depths that these grades were located at, starting at 12 meters.
Inovio {NYSE: INO} reported their Second Quarter Financial Results.
Revenue and expenses were both higher due to the Roche partnership and costs incurred in preparation for future clinical trials.
Cash on hand is $109 million, sufficient for working capital requirements until 2017.
